À¤³¦¤Î·ò¹¯¥Ë¥å¡¼¥¹²òÀâ
»éËûÀ¤¬´Ø¤ï¤ë¥¢¥ì¥ë¥®¡¼¤ÈÓé¡Ê1¡Ë
¡Ê¹³ÂΤΥᥫ¥Ë¥º¥à¡Ë
¥¢¥ì¥ë¥®¡¼¤Ï4¿Í¤Ë°ì¿Í¤¬»ý¤Ä¤È¤¤¤ï¤ì¤ëÌȱֲá¾ê¼À´µ¡£
¥Þ¥¹¥³¥ß¤ÎÊóÆ»¤Ï°ìÈÌ¿Í¤Ë¤ÏÆñ²ò¤Ç¤¹¤¬¡¢°å³Ø³¦¤Î¶È³¦ÍѸ줽¤Î¤Þ¤Þ¤¬°î¤ì¤Æ¤¤¤ë¤«¤é¤Ç¤¹¡£
TºÙ˦¤Ï¶»Á£ºÙ˦¡¢BºÙ˦¤Ï¹ü¿ñºÙ˦¤È¸Æ¤Ù¤Ð¿È¶á¤Ç¤¹¡£¶È³¦ÍѸì¤È¤¤¤¨¤É¤â±Ñ¸ì¤ÎƬʸ»ú¤ò»ÈÍѤ·¤Æ¤¤¤ë¤À¤±¡£¾Êά¤·¤Ê¤¤¸¶¸ì¤«¡¢ÆüËܸì¤Ê¤é¤Ð³ÊÃʤËÍý²ò¤·¤ä¤¹¤¯¤Ê¤ê¤Þ¤¹¡£
- ¹ü¿ñºÙ˦¡ÊBºÙ˦¡Ë¤È¶»Á£ºÙ˦¡ÊTºÙ˦¡Ë
- ¹³ÂΤÈÌȱ֥°¥í¥Ö¥ê¥ó
- ²ÖÊ´¾É¡¢Óé¤Ê¤É¥¢¥ì¥ë¥®¡¼¤Ë´Ø·¸¤¹¤ëIgE¹³ÂΤÈIgA¹³ÂÎ
- IgE¹³ÂΤ¬»éËúÙ˦¡Ê¥Þ¥¹¥ÈºÙ˦¡Ë¤è¤êͳ²²½³ØÅÁãʪ¼Á¤ò»ºÀ¸¤µ¤»¤ë
- ²ÖÊ´¾É¡¢Óé¤Ê¤É¤Î¸¶°ø¤È¤Ê¤ë²½³ØÅÁãʪ¼Á¡¢¥í¥¤¥³¥È¥ê¥¨¥ó¡ÊLT¡Ë¤È¥È¥í¥ó¥Ü¥¥µ¥ó¡ÊTX¡Ë
- ¤·ì´´ºÙ˦¡ÊBlood Stem Cell¡Ë¤ÈÌȱֺÙ˦¡Êimmunocytes¡Ë
- Çò·ìµå¡Êleukocyte, a white blood cell, white corpuscles¡Ë
- ðùγµå¤È¸Æ¾Î¤µ¤ì¤ë¹¥Ãæµå¡Êneutrophil¡Ë¡¢¹¥±ö´ðµå¡Êbasophil¡Ë¡Ê¤³¤¦¤¨¤ó¤¤¤å¤¦¡Ë¡¢¹¥»Àµå¡Êeosinophil¡Ë¡¢ÈîËþºÙ˦¡Ê¥Þ¥¹¥ÈºÙ˦¡§Mast cells¡Ë¡£
¹¥Ãæµå¤¬Çò·ìµåÁ´ÂΤÎ50¡ó°Ê¾å¤òÀê¤á¤Þ¤¹¡£
- ñµå¤È¸Æ¾Î¤µ¤ì¤ë¥Þ¥¯¥í¥Õ¥¡¡¼¥¸¡ÊìÅ¿©ºÙ˦¡§macrophage¡Ë¡¢
- ¥ê¥ó¥Ñµå¡Êlymphocyte¡Ë¤È¸Æ¾Î¤µ¤ì¤ë¹ü¿ñºÙ˦¡ÊBºÙ˦¡Ë¡¢¶»Á£ºÙ˦¡ÊTºÙ˦¡Ë¡¢¥Ê¥Á¥å¥é¥ë¥¥é¡¼ºÙ˦¡ÊNKºÙ˦¡Ë
°¶Ì¹³ÂΤÎIgE¤¬¥¢¥ì¥ë¥®¡¼À¼À´µ¤Î¸¶°øÊª¼Á¤òÀ¸¤ß½Ð¤¹¤Î¤Ï¡¢ÈîËþºÙ˦¡¢¹¥±ö´ðµå¡Êbasophil¡Ë¡¢¹¥»Àµå¡Êeosinophil¡Ë¤Ç¤¹¡£
- ÈîËþºÙ˦¡Ê¥Þ¥¹¥ÈºÙ˦¡§Mast cells¡Ë
- »éËúÙ˦¡Ê¥Þ¥¹¥ÈºÙ˦¡Ë¤Ï¿ÍÂΤΤ¢¤é¤æ¤ëÉô°Ì¤Ë¸ºß¤·¤Þ¤¹¤¬¡¢ÆÃ¤ËÈéÉæ¡¢ÌÜ¡¢É¡¤Ê¤ÉÇ´ËìÁÈ¿¥¤Ë¿¤¯Â¸ºß¤·¤Þ¤¹¡£»é¼Á¤¬ÃßÀѤ¹¤ë¤È¥µ¥¤¥º¤¬Â礤¯¤Ê¤ê¤Þ¤¹¡£ÈîËþºÙ˦¤Ï¥¢¥ì¥ë¥®¡¼¤Ë´ØÏ¢¤¹¤ë¾¡¢¿´Â¡·ì´É´ØÏ¢¼ÀɤäÈîËþ¤Ë´ØÏ¢¤¹¤ë³Æ¼ï¥Û¥ë¥â¥ó¤òʬÈ礹¤ë¤³¤È¤¬ÌÀ¤é¤«¤Ë¤Ê¤ê¡¢¤³¤ÎÃæ¤Ç¤â¥¢¥Ç¥£¥Ý¥Í¥¯¥Á¥ó¤È¥ì¥×¥Á¥ó¤È¤Î¸¦µæ¤¬¿Ê¤ß¤Ä¤Ä¤¢¤ê¤Þ¤¹¡£
- ¥¢¥Ç¥£¥Ý¥Í¥¯¥Á¥ó(adiponectin)
- ¥ì¥×¥Á¥ó¡ÊLeptin)
- ¼«Á³Ìȱ֡Êinnate immunity¡Ë¤È³ÍÆÀÌȱ֡Êadaptive immunity¡Ë
¹³ÂΤò¤¤ëºÙ˦¡Êcell)¤Ï¹ü¿ñͳÍè¤Î¹ü¿ñºÙ˦¤Ç¤¹¡£¹ü¿ñ¡Êbone marrow¡Ë¤ÎƬʸ»ú¤ÇBºÙ˦¤È¸Æ¤Ð¤ì¤Þ¤¹¡£¤³¤ÎºÙ˦¤ËÅÁãʪ¼Á¡Ê¥µ¥¤¥È¥«¥¤¥ó¡§cytokine¡Ë¤Ç»ØÎá¤òÍ¿¤¨¤ë¤Î¤¬Â¿ÅÄÉÙͺÇî»Î¤Îȯ¸«¤ÇÃøÌ¾¤Ê¥Ø¥ë¥Ñ¡¼TºÙ˦¡ÊTh2ºÙ˦¡Ë¤Ç¤¹¡£¥Ø¥ë¥Ñ¡¼TºÙ˦¤Ï¶»Á£¡ÊThymus¡Ë¤Ç¤¤é¤ì¤ë¶»Á£ºÙ˦¡ÊThymus¤ÎƬʸ»ú¤ÇTºÙ˦¡Ë¤Î£±¼ï¤Ç¤¹¡£¹ü¿ñºÙ˦¤ÎƯ¤¤ò½õ¤±¤ë¤³¤È¤«¤é̾ÉÕ¤±¤é¤ì¤Þ¤·¤¿¡£Th¤Îh¤Ïhelper¤ÎƬʸ»ú¡£¥µ¥¤¥È¥«¥¤¥ó¤Ï¹¤¤°ÕÌ£¤ò»ý¤Ä¸ÀÍդǡ¢¥¤¥ó¥¿¡¼¥í¥¤¥¥ó¡ÊInterleukin¡§IL¤È¾Êά¤µ¤ì¤ë¡Ë¤Ê¤É¿ôÉ´¼ïÎब¤¢¤ë¤È¤¤¤ï¤ì¤ë¥Û¥ë¥â¥óÍÍÅÁãʪ¼Á¡ÊºÙ˦´Ö¤Î¥³¥ß¥å¥Ë¥±¡¼¥·¥ç¥óµ¡Ç½¡Ë¤Ç¤¹¡£
·ì´É¤ä¥ê¥ó¥Ñ´É¤ò½Û´Ä¤¹¤ëÇò·ìµå¤Î7³ä¤òÀê¤á¤ë¤Î¤¬¶»Á£ºÙ˦¡ÊTºÙ˦¡Ë¤Ç¤¹¤¬¡¢TºÙ˦¤Ë¤Ï¾¤Ë¼«Ê¬¼«¿È°Ê³°¤ò»¦¤¹¥¥é¡¼TºÙ˦(Killer T cell)¡¢¤½¤ì¤òÍÞÀ©¡Êsuppress)¤¹¤ë¥µ¡¼¥×¥ì¥Ã¥µ¡¼TºÙ˦¡ÊSuppressor T cell¡Ë¤¬¤¢¤ê¤Þ¤¹¡£ÆüËܤοÅÄÉÙͺÇî»Î¤¬¤³¤ÎʬÌî¤ÎÂè°ì¿Í¼Ô¤Ç¤¹¡£
¹³ÂÎ(¥¢¥ó¥Á¥²¥ó¡§antigen)¤ÎÊÌ̾¤¬Ìȱ֥°¥í¥Ö¥ê¥ó¡ÊImmunoglobulin¡Ë¤Ç¤¹¡£Ig¤Çɽ¤µ¤ì¤Þ¤¹¡£
¹³ÂΤϿ¯Æþ¹³¸¶¡Ê¥¢¥ì¥ë¥²¥ó¡§allergen¡Ë¤Ë¤¢¤ï¤»¤ÆÌµ¿ô¡Ê¿ôÀéËü¤«¤é1²¯¤È¤â¸À¤ï¤ì¤Æ¤¤¤ë¡Ë¤Ëºî¤é¤ì¤ë¤¿¤ó¤Ñ¤¯¼Á¤Ç¤¹¡£¹³ÂΤÏÂçIgA¡¢IgE¡¢IgM¡¢IgG¡¢IgD¤Î5¼ïÎà¤Î¥¯¥é¥¹¤ËÂçÊ̤µ¤ì¤Æ¤¤¤Þ¤¹¤¬¡¢µ¹æ¤Ë¤¢¤ëIg¤ÏÌȱ֥°¥í¥Ö¥ê¥ó¡ÊImmunoglobulin¡Ë¤Îά¸ì¤Ç¤¹¡£¹³ÂΡÊÌȱ֥°¥í¥Ö¥ê¥ó¡Ë¤Î80%°Ê¾å¤òÀê¤á¤ë¤Î¤¬IgG¤Ç¤¹¡£
¹³ÂΤˤÏɵ¤¤òËɤ°½ÅÍ×¤ÊÆ¯¤¤¬¤¢¤ëÈ¿ÌÌ¡¢¸µÍè̵³²¤Ê²ÖÊ´¤ä¥Ï¥¦¥¹¥À¥¹¥È¤Ë²á¾êÈ¿±þ¤·¤ÆÀ¸ÂΤò½ý¤Ä¤±¤ë¹³ÂΤ⤢¤ê¤Þ¤¹¡£¤³¤ÎÃæ¤Ç¤âIgE¹³ÂΤÏÓé¤ä²ÖÊ´¾É¤Ë´Ø¤ï¤ëͳ²ºîÍÑʪ¼Á¤ò»ºÀ¸¤¹¤ë°¶Ì¹³ÂΤȤ·¤ÆÃΤé¤ì¤Æ¤¤¤Þ¤¹¡£¤³¤Î½ÅÍפʰ¶Ì¹³ÂΤòȯ¸«¤·¤¿¤Î¤ÏÀÐºä¸øÀ®Çî»Î¤Ç¤¹¡£ºÇ½ªÅª¤ËÊÆ¹ñ¥«¥ê¥Õ¥©¥ë¥Ë¥¢½£¥é¡¦¥Û¥ä¤Î¥¢¥ì¥ë¥®¡¼¸¦µæ½ê¤Ç¸¦µæ¤ò¤µ¤ì¤¿Êý¤Ç¤¹¤¬¡¢¥¢¥ì¥ë¥®¡¼Ê¬Ìî¤Ç¤Î¿Âç¤Ê¸ùÀӤˤè¤êʸ²½·®¾Ï¤ò¼øÍ¿¤µ¤ì¤Æ¤¤¤Þ¤¹¡£
IgE¹³ÂΤÎÎ̤Ï5¤Ä¤Î¹³ÂΤÎÃæ¤ÇºÇÄã¤Î£±%°Ê²¼¤Ç¤¹¤¬¡¢¶¯¤¤µ¡Ç½¤ò»ý¤Á¤Þ¤¹¡£
·ò¹¯¤Ê¿Í¤Ë³Ó¤Ù¤Æ¥¢¥È¥Ô¡¼´µ¼Ô¤ËÈó¾ï¤Ë¿¤¯¤ß¤é¤ì¤Þ¤¹¤¬¡¢Ê¸ÌÀŪ¤Ê¹ṉ̃¤Û¤ÉIgE¹³ÂΤ¬Â¿¤¯¤Ê¤ë¤È¤¤¤ï¤ì¤Æ¤¤¤Þ¤¹¡£
IgA¹³ÂΤϹ³ÂÎÁ´ÂΤÎ10%¤¯¤é¤¤¤òÀê¤á¤Þ¤¹¡£IgA¤¬Â¿¤±¤ì¤ÐIgE¤ÏÙɹ³¤·¤ÆÀ©¸æ¤µ¤ì¡¢¥¢¥ì¥ë¥®¡¼¤Ïµ¯¤Æñ¤¯¤Ê¤ê¤Þ¤¹¤«¤é¡¢¥¢¥È¥Ô¡¼´µ¼Ô¤ÏIgA¤¬Ä̾ï¤Î¿Í¤è¤êÂçÉý¤Ë¾¯¤Ê¤¤¤È¤¤¤ï¤ì¤Þ¤¹¡£
²ÖÊ´¤ä¥Ï¥¦¥¹¥À¥¹¥È¤Ê¤É¤Î¹³¸¶¡Ê¥¢¥ì¥ë¥²¥ó¡Ë¤È·ë¹ç¤·¤¿IgE¹³ÂΤϡ¢ÈîËþºÙ˦¡Ê¥Þ¥¹¥ÈºÙ˦¡§Mast cells¡Ë¤Ê¤É¤ÎºÙ˦Ëì¼õÍÆÂΤȷë¹ç¤·¤ÆÓé¤ä²ÖÊ´¾É¤Î¸¶°ø¤È¤â¤Ê¤ëͳ²¤Ê³Æ¼ï¤Î²½³ØÅÁãʪ¼Á¡Ê¥±¥ß¥«¥ë¥á¥Ç¥£¥¨¡¼¥¿¡¼¡Ë¤òÊü½Ð¡ÊÍ·Î¥¡Ë¤µ¤»¤Þ¤¹¡£
¤³¤Î»þ¤Ë¹³¸¶¤òǧ¼±¤·¤ÆÅÁãʪ¼Á¡Ê¥µ¥¤¥È¥«¥¤¥ó¡Ë¤Ë¤è¤ê»ØÎá¤òÍ¿¤¨¤ë¤Î¤¬¶»Á£ºÙ˦¤Î°ì¼ï¤Ç¤¢¤ë¥Ø¥ë¥Ñ¡¼TºÙ˦¤Ç¤¹¡£»ØÎá¤ò¼õ¤±¤¿¹³ÂΤÏÈîËþºÙ˦¡Ê¥Þ¥¹¥ÈºÙ˦¡§Mast cells¡Ë¤Ê¤É¤ÎºÙ˦Ëì¼õÍÆÂΤȷë¹ç¤·¤Æ²½³ØÅÁãʪ¼Á¡Ê¥±¥ß¥«¥ë¥á¥Ç¥£¥¨¡¼¥¿¡¼¡Ë¤òÍ·Î¥¤µ¤»¤Þ¤¹¡£
»éËúÙ˦¤Ê¤É¤¬Í·Î¥¤¹¤ëͳ²¤Ê²½³ØÅÁã¡ÊÍ·Î¥¡Ëʪ¼Á¡Ê¥±¥ß¥«¥ë¥á¥Ç¥£¥¨¡¼¥¿¡¼¡Ë¤Ë¤Ï¡¢¥Ò¥¹¥¿¥ß¥ó(Histamine)¡¢¥í¥¤¥³¥È¥ê¥¨¥ó(Leukotriens)¡¢¥È¥í¥ó¥Ü¥¥µ¥ó(Thromboxane)¤Ê¤É¤¬¤¢¤ê¤Þ¤¹¡£
¥í¥¤¥³¥È¥ê¥¨¥ó¡ÊLT¤Çɽ¤µ¤ì¤Þ¤¹¡§Çò·ìµå¤ÎleukocyteͳÍè¤Î¥Í¡¼¥ß¥ó¥°¡Ë¤Ï¥Ò¥¹¥¿¥ß¥ó¤Ë³Ó¤Ù¿ôÀ餫¤é10000Çܤâ¤Î³èÀºîÍѤ¬¤¢¤ëʪ¼Á¤È¤¤¤ï¤ì¡¢±ê¾É¤Î¸¶°øÊª¼Á¤È¤Ê¤ê¤Þ¤¹¡£¥È¥í¥ó¥Ü¥¥µ¥ó¤Ïµ¤´É»ÙÊ¿³ê¶Ú¤ä·ì´ÉÊ¿³ê¶Ú¤ò¼ý½Ì¤µ¤»¤Þ¤¹¡£
¤Þ¤¹¡£
¤³¤Îͳ²²½³ØÅÁãʪ¼Á¡Ê¥±¥ß¥«¥ë¥á¥Ç¥£¥¨¡¼¥¿¡¼¡Ë¤Î¸¶ÎÁ¤È¤Ê¤ë¤Î¤¬¿¢ÊªÀ¿©ÍÑÌý¤Î¥ª¥á¥¬6»éËûÀ¤Ç¤¹¡£¡Ê»éËûÀ¤¬´Ø¤ï¤ë¥¢¥ì¥ë¥®¡¼¤ÈÓé¡¢ÍѸì²òÀâÊФò»²¾È¡Ë
Óé¤ä²ÖÊ´¾É¤ÎÂоÉÎÅË¡¤ËÍѤ¤¤é¤ì¤ë¤Î¤¬¡¢¤³¤Î²½³ØÊª¼ÁÍ·Î¥¤òÍÞÀ©¤¹¤ë¹³¥í¥¤¥³¥È¥ê¥¨¥óÁ˳²ºÞ¡¢¹³¥È¥í¥ó¥Ü¥¥µ¥óÁ˳²ºÞ¤Ç¤¹¡£
¤·ì´´ºÙ˦¤Ï·ìµå¤ÎÁ´¤Æ¤ò¤¤ë´´ºÙ˦¤Ç¤¹¡£¹ü¿ñ¤Ë¸ºß¤¹¤ë¤Î¤Ï¾¯Î̤Ǥ¹¤¬¡¢Â礤ʤ·ìǽÎϤò»ý¤Á¤Þ¤¹¡£
¤·ì´´ºÙ˦¤Ç¤¤é¤ì¤ë·ìµå¤Ï¡¢ÀÖ¿§Áǥإ⥰¥í¥Ó¥ó¤ò»ý¤ÄÀÖ·ìµå¤È·ì¾®Èġʵð³Ëµå¡Ë°Ê³°¤ÏÌȱַϺÙ˦¤È¸Æ¤Ð¤ì¤ëÇò·ìµå¤Ç¤¹¡£
Çò·ìµå¤ÏÌȱַϺÙ˦¤ÈƱµÁ¸ì¤Ç°Ê²¼¤Î¼ïÎब¤¢¤ê¤Þ¤¹¡£
¥¢¥Ç¥£¥Ý¥Í¥¯¥Á¥ó(adiponectin)¡¦¡¦¡¦¥¤¥ó¥¹¥ê¥ó´¶¼õÀ¥Ö¥É¥¦ÅüÇ»ÅÙÄã²¼¥Û¥ë¥â¥ó¡£
ÅìµþÂç³Ø¤Î»³ÆâÉÒÀµ°å»Õ¡¢ÌçÏÆ ¹§½õ¶µ¼ø¤é¤¬DNA¤Î¥¯¥í¡¼¥Ë¥ó¥°¤ËÀ®¸ù¤·¤Æ¤¤¤Þ¤¹¡£
¥¢¥Ç¥£¥Ý¥Í¥¯¥Á¥ó¤Ï¡¢244¥¢¥ß¥Î»À»Ä´ð¤«¤éÀ®¤ë¥¿¥ó¥Ñ¥¯¼Á¡£»éËúÙ˦¤Ç»ºÀ¸Ê¬È礵¤ì¤Þ¤¹¡£¥¤¥ó¥¹¥ê¥ó¤Ë´¶¼õÀ¤ò¼¨¤·¡¢·ìÃæ¤Î¥Ö¥É¥¦ÅüÇ»ÅÙ¤ò²¼¤²¤ëÌò³ä¤¬¤¢¤ë¥Û¥ë¥â¥ó¤È¤¤¤ï¤ì¤Þ¤¹¡£»éËúÙ˦¤¬¾®¤µ¤¤¤ÈʬÈ礬À¹¤ó¤Ë¤Ê¤ê¡¢ÈîËþ²½¤·¤ÆÂ礤¯¤Ê¤ë¤ÈʬÈ礬°¤¯¤Ê¤ë¤³¤È¤¬²òÌÀ¤µ¤ì¤Æ¤¤¤Þ¤¹¡£
¥Þ¥¦¥¹¥ì¥Ù¥ë¤Ç¤Ï¥¢¥Ç¥£¥Ý¥Í¥¯¥Á¥ó¤Î·ç˳¤ÇÅüǢɤˤʤ뤳¤È¤¬³Îǧ¤µ¤ì¤Æ¤ª¤ê¡¢ÈîËþ¡¢¶·¿ÅüǢɴµ¼Ô¡¢´§Æ°Ì®¼À´µ¤Î¥¢¥Ç¥£¥Ý¥Í¥¯¥Á¥óÇ»Å٤ϷìÞùÃæ¤Ç¸º¾¯¤·¤Æ¤¤¤Þ¤¹¡ÊNature. Jun. 12. 2003¡¢Yamauchi.T et al¡Ë
¥¢¥Ç¥£¥Ý¥Í¥¯¥Á¥ó¤Ï»À²½»éËûÀ¤ÎȯÀ¸¤Ê¤É¤Ç¤ª¤¤ë·ì´É¾ã³²»þ¤Ë¡¢¾ã³²¾ì½ê¤Ë½¸ÀѤ·¤ÆÆ°Ì®¹Å²½ÍÞÀ©¤ËƯ¤¯¤È¤¤¤¦¡¢¤¤¤ï¤Ð·ì´É½¤Éüºà¤ÎÌò³ä¤â»ý¤Ä¤½¤¦¤Ç¤¹¡£
¥ì¥×¥Á¥ó¡ÊLeptin)¡¦¡¦¡¦¿©ÍßÍÞÀ©¡¢»éËÃʬ²ò¥Û¥ë¥â¥ó¡£
¥ì¥×¥Á¥ó¤Ï1994ǯ12·î¤Ë¥í¥Ã¥¯¥Õ¥§¥é¡¼Âç³ØµÚ¤Ó¥Ï¥ï¡¼¥É¡¦¥Ò¥å¡¼¥º°å³Ø¸¦µæ½ê¤Î¥¸¥§¥Õ¥ê¡¼¡¦¥Õ¥ê¡¼¥É¥Þ¥ó¡ÊJeffrey Friedman¡ËÇî»Î¤é¤Ë¤è¤Ã¤Æ¥Í¥¤¥Á¥ã¡¼»ïȯɽ¤µ¤ì¤¿¡¢»éËúÙ˦¤«¤éʬÈ礵¤ì¤ë¥Ú¥×¥Á¥É¥Û¥ë¥â¥ó¤Ç¤¹¡£
¥®¥ê¥·¥ã¸ì¤Î¤ä¤»¤ë¤È¸À¤¦°ÕÌ£¡Êleptos¡Ë¤Ë¤Á¤Ê¤ó¤Ç̿̾¤µ¤ì¤Þ¤·¤¿¡£
¥ì¥×¥Á¥ó¤Ï»ë¾²²¼Éô¤Ë¸ºß¤¹¤ë¥ì¥×¥Á¥ó¼õÍÆÂΤ˷ë¹ç¤·¤Æ¿©ÍßÍÞÀ©¤È»éËÃʬ²ò¡¢³ì¿§ºÙ˦¤Ë¤ª¤¤¤Æ¤Ï¥¨¥Í¥ë¥®¡¼Âå¼Õ¤Îж¿Ê¤òÂ¥¤·¡¢Åü»é¼ÁÂå¼Õ¤Ë±Æ¶Á¤òÍ¿¤¨¤Þ¤¹¡£
¥ì¥×¥Á¥ó·ç»°äÅÁ»Ò¤ò»ý¤Ä²È·Ï¤Ë¡¢¹çÀ®¤·¤¿¥ì¥×¥Á¥ó¤òÅêÍ¿¤¹¤ë¤È°Û¾ïÈîËþ¤¬¼£ÎŤǤ¤¿¤È¤¤¤¦¸¦µæ¤¬¤¢¤ê¤Þ¤¹¡£
¤·¤¿¤¬¤Ã¤Æ¥ì¥×¥Á¥ó¤ÏÈîËþ¤òÍÞÀ©¤¹¤ë¤È¹Í¤¨¤é¤ì¤Æ¤¤¤Þ¤¹¤¬¡¢»éËúÙ˦¤«¤é¤Î¥ì¥×¥Á¥óʬÈçÄã²¼¤Ë¤è¤Ã¤Æ¥ì¥×¥Á¥ó¤Î·ìÃæÇ»ÅÙ¤¬Ä㤯¡¢ÈîËþ¤Ë¤Ê¤Ã¤Æ¤¤¤ë¿Í¤Î³ä¹ç¤Ï¿¤¯¤Ï¤Ê¤¯¡¢90¡ó¤¯¤é¤¤¤ÎÈîËþ¤Î¿Í¤¬Ä̾ï¤ÎBMIÃÍ¡ÊÈîËþÅ١ˤοͤè¤ê¥ì¥×¥Á¥ó·ìÃæÇ»ÅÙ¤¬¹â¤¤¤³¤È¤¬Êó¹ð¤µ¤ì¤Æ¤¤¤Þ¤¹¤Î¤Ç¡¢µ¡Ç½¤ÎÁ´ËƤϤ¤¤Þ¤À¤Ë¸¦µæÃæ¤È¤µ¤ì¤Æ¤¤¤Þ¤¹¡£
¼«Á³Ìȱ֡Êinnate immunity¡Ë¤Ï¹¤¤ÈÏ°Ï¤ÎÆ°Êª¤¬»ý¤Ä´ðËÜŪ¤ÊÌȱ֡£É¸¶ÂΤ乳¸¶¡Ê¥¢¥ì¥ë¥²¥ó¡§allergen¡Ë¤Ø¤ÎÀ¸ÂÎËɸæÈ¿±þ¤Ç¤¹¡£
³ÍÆÀÌȱ֡Êadaptive immunity¡Ë¤ÏÀÔÄÇÆ°Êª¤Ë¸Â¤é¤ì¤Þ¤¹¡£ÂÎÆâ¤Ë¿¯Æþ¤·¤¿É¸¶ÂΤμïÊ̤ò¼±Ê̤·¡¢Å¬Àµ¤ÊÂбþ¡ÊŬ±þ¡Ë¤ò¤µ¤»¤ëÌȱֺîÍѤǤ¹¡£
³ÍÆÀÌÈ±Ö¤ËÆ¯¤¯ÌȱֺÙ˦¤Î·Á¾õ¤¬¼ùÌÚŪ¤ËÆÍµ¯¤¬¤¢¤ë¤¿¤á¤Ë¼ù¾õºÙ˦¡Êdendritic cell¡Ë¤È¸Æ¤Ð¤ì¤Þ¤¹¡£
¼ù¾õºÙ˦¤ÏÀÔÄÇÆ°Êª¤Ë¿¯Æþ¤·¤¿É¸¶ÂΤμïÊ̤ò¼±Ê̤¹¤ëÀèʼ¤ÎƯ¤¤ò¤·¤Þ¤¹¡£
¹³¸¶Ä󼨺Ù˦¤È¤â¤¤¤ï¤ì¡¢¼è¤ê¹þ¤ó¤Àɸ¶ÂÎ¡Ê pathogens¡Ë¤Î¾ðÊó¤ò¡¢¹³ÂΤȤʤëTºÙ˦¡¢BºÙ˦¤Ê¤É¾¤ÎÌȱַϺÙ˦¤ËÅÁ¤¨¡¢Âбþ¡ÊŬ±þ¡Ë¤ò¤µ¤»¤Þ¤¹¡£
¼ù¾õºÙ˦¤Ï¤³¤ÎÂбþ¤ÇÂκÙ˦¤Ë¹âÉÑÅÙÊѰۡÊSomatic hypermutation¡Ë¤òµ¯¤³¤µ¤»¤ë¤³¤È¤¬ÃΤé¤ì¤Æ¤ª¤ê¡¢¤³¤ÎƯ¤¤¬Å¬±þ¡Êadaptive¡Ë¤È¤¤¤¦¸ÀÍդθµ¤È¤Ê¤Ã¤Æ¤¤¤Þ¤¹¡£
㊟2011ǯ¤Î¥Î¡¼¥Ù¥ë°å³ØÀ¸Íý³Ø¾Þ¤Ï¡¢¤³¤ì¤é¤ÎÌȱ֥·¥¹¥Æ¥à¤ò²òÌÀ¤·¤¿¥í¥Ã¥¯¥Õ¥§¥é¡¼Âç³Ø¡ÊUniv.of Rockefeller)¤Î¥¹¥¿¥¤¥ó¥Þ¥óÇî»Î¡ÊRalph M. Steinman¡Ë¤é»°¿Í¤Ç¤·¤¿¡£
¾Þ¤ÏȾʬ¤¬¥Æ¥¥µ¥¹Âç³Ø¡ÊUniversity of Texas Southwestern Medical Center¡Ë¤Î¥Ü¥¤¥È¥é¡¼Çî»Î¡ÊBruce A. Beutler¡Ë¤È¡¢¥Õ¥é¥ó¥¹ºß½»¡Êthe National Center of Scientific Research ¡§CNRS)¤Î¥Û¥Õ¥Þ¥óÇî»Î¡ÊJules A. Hoffmann¡Ë¤é¤Î¼«Á³ÌȱÖÍýÏÀ¡Êinnate immunity¡Ë¡£
Ⱦʬ¤¬¥¹¥¿¥¤¥ó¥Þ¥óÇî»Î¤Î¼ù¾õºÙ˦¡Êdendritic cell¡Ë¤Îȯ¸«¤È¡¢¤½¤ì¤¬Ìò³ä¤ò²Ì¤¿¤¹³ÍÆÀÌȱÖÍýÏÀ¡ÊŬ±þÌȱ֡§adaptive immunity¡Ë¡£
ÌȱÖÍýÏÀ¤Î¸¦µæ¤ÏÆüËܤâ¿Ê¤ó¤Ç¤ª¤ê¡¢1987ǯ¤Î¥Î¡¼¥Ù¥ë°å³ØÀ¸Íý³Ø¾Þ¤ÏÍøº¬Àî¿ÊÇî»Î¤¬¹³ÂΤΰäÅÁ»Ò¤Ë´Ø¤¹¤ë¸¦µæ¤Ç¼õ¾Þ¡£
»Äǰ¤Ê¤¬¤éÆüËܿͤÎÍÎϸ¦µæ¼Ô¤Î¿¤¯¤ÏÊÆ¹ñ¤Ç¸¦µæ¤ò¤·¤Æ¤¤¤Þ¤¹¡£
µûÌý¡ÊEPA/DHA¡Ë¤Î¹³±ê¾É¥á¥«¥Ë¥º¥à¤ò²òÌÀ¡§
¥ì¥½¥ë¥Ó¥óD£²¡ÊResolvin D2¡Ë¤È¤Ï
¥Î¡¼¥Ù¥ë°å³ØÀ¸Íý³Ø¾Þ¡Ê2009ǯ¡Ë¤ò¼õ¾Þ¤·¤¿¥Æ¥í¥á¥é¡¼¥¼¤Îȯ¸«¡§
¥Æ¥í¥á¥é¡¼¥¼¤Ï¥ì¥¹¥Ù¥é¥È¥í¡¼¥ë¸¦µæ¤ÎÅÚÂæ
¥¸¥¢¥·¥ë¥°¥ê¥»¥í¡¼¥ë¤Î¿©ÍÑÌý¤Ëµ¿ÌäÉä¡ÊºÆ¡Ë
²Ö²¦¤Î¥¯¥Ã¥¥ó¥°¥ª¥¤¥ë¡§¥¨¥³¥Ê¤¬ÆÍÁ³¤ÎÈÎÇäÄä»ß
ÊÆ¹ñÀ¯Éܤ¬¥¢¥Ø¥óËÐÌǤÎÂçºîÀﳫ»Ï
¥¢¥Õ¥¬¥Ë¥¹¥¿¥ó¤ÏÀ¤³¦°ì¤Î³©»Ò¡Ê¤±¤·¡ËºÏÇÝÃÏ

<<< ¥Î¥®¥Ü¥¿¥Ë¥«¥ë¤Î¥È¥Ã¥×¥Ú¡¼¥¸¤Ø
¡¡ËÜ¥µ¥¤¥È¤¬·ÇºÜ¤¹¤ë¾ðÊ󡦲èÁüÅù¤Ï¡¢Äó·È¥µ¥¤¥È¤Î¾ÅÆî¾ðÊó¥µ¥¤¥È¡Ö¥í¥Ï¥¹¥±¡×ÊÔ½¸Éô¤è¤êÄ󶡤µ¤ì¤Æ¤¤¤Þ¤¹¡£
Ãøºî¸¢¤Ï¡Ö¥í¥Ï¥¹¥±¡×ÊÔ½¸Éô¤Ë°¤·¤Þ¤¹¡£
¸¢Íø¼Ô¤Îµö²Ä¤Ê¤¯Ê£À½¡¢Å¾ÍÑ¡¢ÈÎÇä¤Ê¤É¤ÎÆó¼¡ÍøÍѤò¤¹¤ë¤³¤È¤ò¸Ç¤¯¶Ø¤¸¤Þ¤¹¡£¾¦¶ÈÌÜŪ¤Ëµ»ö¤ò°úÍÑ¡¢Å¾¼Ì¤¹¤ë¾ì¹ç¤Ï¡¢°úÍÑ:°ì¹à30,000±ß¡¢Å¾¼Ì:50,000±ß¤È¤Ê¤ê¤Þ¤¹¡£